Abstract
The present invention relates to a composition comprising a hydrophilic drug and an amphiphilic carbohydrate compound for use in therapy wherein the composition is intranasally administered to the human or animal body. The composition can be used to treat a variety of disorders, including schizophrenia, obesity, pain and sleep disorders, psychiatric diseases, neurodegenerative conditions, brain cancers and infective diseases.
| Original language | English |
|---|---|
| Patent number | PCT/GB2014/053254, |
| IPC | A61K 47/36 (2006.01), A61K 38/08 (2006.01) |
| Priority date | 4/11/14 |
| Publication status | Published - 7 May 2015 |
Keywords
- Peptide, Nanomedicines, Nasal
